Fund
-
Quintiles, Biofund to expand clinical development capabilities in Russia
Russian venture company (RVC), Biofund, and Quintiles announced an agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.
Fund | 13 April 2012
-
Telormedix secures further funding
Telormedix announced that it has raised 7.5 million CHF (US$8.1 million) from existing investors Aravis Venture and Proquest Investments.
Fund | 17 February 2012
-
Funding enables use of Solid 4 for cancer biomarker research
Life Technologies and University of California at San Diego (UCSD) Moores Cancer Center announces a partnership to use Solid 4 genomic analysis technology in a research program to study chronic lymphocytic leukemia (CLL), a cancer of the white blood…
Fund | 24 August 2010
-
Galantos Pharma Raises Funds to Advance Alzheimer`s Dementia Strategy
Galantos Pharma has announced the successful finalization of its C financing round to bring its leading compound Memogain for Alzheimer’s Dementia (AD) into the clinic and to develop novel neuroprotective AD compounds. The investors VRP (Rhinel…
Fund | 12 May 2010
-
Hunter Immunology Seeks Funding for Clinical Trial
Australia-based biotechnology company Hunter Immunology is seeking to raise $8-10 million to fund a Phase IIb clinical trial of its lead product HI-164OV. The capital raising is cornerstoned by the IB Australian Bioscience Fund which has already …
Fund | 23 April 2010
-
IB Launches Asia Pacific Health Fund
Melbourne-based IB Australian Bioscience Fund is launching an Asia Pacific healthcare fund, following the success of its IB Bioscience Fund I. The latest opportunity is known as the IB Asia Pacific Healthcare Fund II. Its focus is healthcare and m…
Fund | 19 March 2010
-
MEDINA Scientists Select Genedata for Lead Discovery from Natural Products
Genedata and Fundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en AndalucÃa), have announced their collaboration in the discovery of innovative medical compounds to fight infectious diseases, cancer and immune dis…
Fund | 30 December 2009
-
GE Launches US$250 Million Healthymagination Fund
GE has announced the formation of the “GE Healthymagination Fundâ€, an equity fund that will make investments in promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sc…
Fund | 11 November 2009
-
BrainStorm Cell Therapeutics Secures Funding for ALS Pre-Clinical Trials
BrainStorm Cell Therapeutics has announced that it has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Ph…
Fund | 21 September 2009
-
NZ and Singapore set up first joint R&D research fund in heart disease and cancer
Singapore’s Agency for Science, Technology and Research (A*STAR) has teamed up with the Health Research Council of New Zealand (HRC) to launch the new A*STAR-NZ Joint Research Fund worth $2.31 million for research in heart disease and cancer. T…
Fund | 20 October 2008
